NDT Advance Access originally published online on November 17, 2005
Nephrology Dialysis Transplantation 2006 21(2):532-534; doi:10.1093/ndt/gfi275
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Teaching Point
(Section Editor: A. Meyrier)
Fulminant sclerosing peritonitis immediately following acute bacterial peritonitis
Regional Nephrology Unit, Level 11, Belfast City Hospital, Belfast, UK
Correspondence and offprint requests to: Aisling E. Courtney, Regional Nephrology Unit, Level 11, Belfast City Hospital, Belfast, UK. Email: aecourtney{at}doctors.org.uk
Sclerosing peritonitis (SP) is an uncommon disease in the peritoneal dialysis population, but the considerable morbidity and mortality associated with it make early diagnosis and treatment imperative. We describe a case illustrating that a fulminant variant of SP can occur as a second phase phenomenon immediately following treatment of acute bacterial peritonitis, a setting in which the diagnosis may be masked and aggressive immunosuppression considered potentially hazardous. Treatment with corticosteroid alone appears particularly effective for SP occurring in this setting.
Keywords: CAPD peritonitis; immunosuppression; inflammation; sclerosing encapsulating peritonitis